Evotec SE announced that Dr. Cord Dohrmann will step down as Chief Scientific Officer on September 30, 2026, after 16 years with the company. His leadership significantly advanced Evotec's scientific capabilities and innovation culture, particularly in emerging technologies like iPSC-based platforms and omics. The company is currently searching for a successor to continue building on this strong scientific foundation, which is crucial for Evotec's future growth and profitability.
Evotec's Chief Scientific Officer transition is noted here with Pluang's health sector data for context. For readers following health stocks, as of Sep 29, 2026 13:12 WIB, 42 of 100 US health stocks rose and 51 fell. Notable movers include ABEO at USD 5.13 (-3.02%), ENVB at USD 1.46 (-2.67%), and CYTK at USD 66.37 (+2.64%) with typical hold times of 23, 13, and 19 days respectively on Pluang.
Eli Lilly's Foundayo (orforglipron) 17.2 mg showed significantly greater weight loss (1.5% more) and A1C reduction (0.3% more) than oral semaglutide 25 mg after 52 weeks in adults with type 2 diabetes, based on an indirect comparison of ACHIEVE-3 and...
Ethlabs has integrated Ethereum Fast Confirmation Rules (FCR) with Chainlink's CCIP 2.0 to speed up Ethereum confirmation times in certain cross-chain transactions. This system uses validator consensus to provide an early confirmation signal, reducin...
Gold experienced a rare 3.4% single-day decline due to surging U.S. Treasury yields and increased expectations of Federal Reserve rate hikes, hitting its lowest in over seven weeks. Bitcoin also fell toward $83,000, pressured by the same macroeconomi...
AstraZeneca is investing $2 billion in Summit Therapeutics to collaborate on cancer drug development, acquiring about 12% of Summit's common stock. The partnership will start clinical trials combining Summit’s ivonescimab with AstraZeneca’s sonesitat...
Card Factory reported a 5.3% revenue increase to £260.8 million in the first half, maintaining its full-year profit forecast despite weaker UK store sales. Adjusted profit before tax fell slightly by 3.8% to £12.7 million due to investments in digita...
